APOA4 antibody (AA 239-371)

Catalog No. ABIN7872648

The Mouse Monoclonal anti-APOA4 antibody is suitable to detect APOA4 in samples from Human. It has been validated for IHC (p).

Quick Overview for APOA4 antibody (AA 239-371) (ABIN7872648)

Target: APOA4 (Apolipoprotein A-IV (APOA4))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This APOA4 antibody is un-conjugated

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: APOA4-3654

Product Details anti-APOA4 Antibody

Binding Specificity: AA 239-371

Purpose: Apolipoprotein A4 Antibody / APOA4

Purification: Protein A/G affinity

Immunogen: A human recombinant APOA4 protein fragment (within amino acids 239-371) was used as the immunogen for the Apolipoprotein A4 antibody.

Isotype: IgG1

Application Details

Application Notes: Optimal dilution of the Apolipoprotein A4 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Aliquot the Apolipoprotein A4 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for APOA4

Target: APOA4 (Apolipoprotein A-IV (APOA4))

Alternative Name: Apolipoprotein A4

Background: Apolipoproteins are protein components of plasma lipoproteins. The human apoA-I gene encodes a single chain, 243 amino acid protein which promotes cholesterol efflux from tissues to the liver for excretion. Apolipoprotein A-I is the major protein component of high density lipoprotein (HDL) in the plasma. It can function as a cofactor for lecithin cholesterolacyltransferase (LCAT), which is responsible for the formation of most plasma cholesteryl esters. The human apoA-II gene encodes the second most abundant protein of HDL particles, where it influences plasma levels of free fatty acids (FFA). The human apoA-IV gene encodes a 396 amino acid preprotein, which after proteolytic processing is secreted from the intestine in association with chylomicron particles. ApoA-IV is a potent activator of LCAT in vitro. The human apoA-V gene encodes a 366 amino acid protein that is believed to be an important determinant of plasma triglyceride levels.

UniProt: P06727

Pathways: Lipid Metabolism